Becton, Dickinson and Company (BDX) Shares Sold by Knights of Columbus Asset Advisors LLC

Knights of Columbus Asset Advisors LLC trimmed its position in shares of Becton, Dickinson and Company (NYSE:BDX) by 3.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 15,190 shares of the medical instruments supplier’s stock after selling 500 shares during the period. Becton, Dickinson and accounts for 2.0% of Knights of Columbus Asset Advisors LLC’s investment portfolio, making the stock its 14th biggest holding. Knights of Columbus Asset Advisors LLC’s holdings in Becton, Dickinson and were worth $2,976,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Westwood Holdings Group Inc. boosted its stake in shares of Becton, Dickinson and by 24.2% during the 2nd quarter. Westwood Holdings Group Inc. now owns 1,056,487 shares of the medical instruments supplier’s stock valued at $206,136,000 after buying an additional 205,721 shares during the period. Colony Group LLC lifted its stake in shares of Becton, Dickinson and by 2.1% in the 2nd quarter. Colony Group LLC now owns 11,889 shares of the medical instruments supplier’s stock valued at $2,320,000 after purchasing an additional 239 shares during the last quarter. State Street Corp lifted its stake in shares of Becton, Dickinson and by 3.5% in the 2nd quarter. State Street Corp now owns 10,270,221 shares of the medical instruments supplier’s stock valued at $2,003,834,000 after purchasing an additional 342,873 shares during the last quarter. Peapack Gladstone Financial Corp lifted its stake in shares of Becton, Dickinson and by 1.3% in the 2nd quarter. Peapack Gladstone Financial Corp now owns 36,472 shares of the medical instruments supplier’s stock valued at $7,116,000 after purchasing an additional 453 shares during the last quarter. Finally, Janney Montgomery Scott LLC lifted its stake in shares of Becton, Dickinson and by 35.3% in the 2nd quarter. Janney Montgomery Scott LLC now owns 43,293 shares of the medical instruments supplier’s stock valued at $8,447,000 after purchasing an additional 11,300 shares during the last quarter. Hedge funds and other institutional investors own 87.91% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://sportsperspectives.com/2017/11/24/becton-dickinson-and-company-bdx-shares-sold-by-knights-of-columbus-asset-advisors-llc.html.

Becton, Dickinson and Company (BDX) opened at $224.23 on Friday. The company has a market cap of $51,119.57, a price-to-earnings ratio of 23.63, a P/E/G ratio of 1.76 and a beta of 1.04. Becton, Dickinson and Company has a twelve month low of $161.29 and a twelve month high of $227.50. The company has a quick ratio of 5.01, a current ratio of 5.56 and a debt-to-equity ratio of 1.48.

Becton, Dickinson and (NYSE:BDX) last announced its earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 EPS for the quarter, topping the consensus estimate of $2.37 by $0.03. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.14 billion. Becton, Dickinson and had a net margin of 8.52% and a return on equity of 22.51%. The business’s quarterly revenue was down 2.0% on a year-over-year basis. During the same quarter last year, the firm posted $2.12 EPS. analysts expect that Becton, Dickinson and Company will post 10.63 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Investors of record on Friday, December 8th will be issued a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.34%. The ex-dividend date of this dividend is Thursday, December 7th. This is an increase from Becton, Dickinson and’s previous quarterly dividend of $0.73. Becton, Dickinson and’s dividend payout ratio (DPR) is 62.80%.

Several research firms recently issued reports on BDX. Stifel Nicolaus reaffirmed a “buy” rating and issued a $245.00 price objective on shares of Becton, Dickinson and in a research note on Friday, November 3rd. Morgan Stanley lifted their price objective on shares of Becton, Dickinson and from $205.00 to $245.00 and gave the company an “equal weight” rating in a research note on Friday, November 3rd. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $230.00 price objective (up previously from $210.00) on shares of Becton, Dickinson and in a research note on Friday, November 3rd. Zacks Investment Research raised shares of Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $234.00 price objective for the company in a research note on Tuesday, October 31st. Finally, Wells Fargo & Company reaffirmed a “positive” rating and issued a $235.00 price objective (up previously from $225.00) on shares of Becton, Dickinson and in a research note on Tuesday, October 24th. They noted that the move was a valuation call. Four research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. Becton, Dickinson and presently has an average rating of “Buy” and a consensus price target of $217.08.

In other news, insider Stephen Sichak sold 11,787 shares of the business’s stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $200.46, for a total transaction of $2,362,822.02. Following the transaction, the insider now owns 14,038 shares in the company, valued at approximately $2,814,057.48. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Gary M. Cohen sold 15,512 shares of the business’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $203.77, for a total transaction of $3,160,880.24. Following the transaction, the insider now owns 95,781 shares in the company, valued at approximately $19,517,294.37. The disclosure for this sale can be found here. Insiders own 1.40% of the company’s stock.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply